LENZ Therapeutics, Inc.
LENZ
$7.34
$0.050.69%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -128.31% | -65.02% | 3.17% | 24.58% | 35.44% |
| Total Depreciation and Amortization | 306.74% | 394.83% | 454.05% | 190.32% | 423.53% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 563.31% | 353.83% | 72.05% | 46.59% | 7.83% |
| Change in Net Operating Assets | 268.10% | 127.67% | 162.65% | 129.38% | -932.51% |
| Cash from Operations | -68.35% | -16.47% | 36.56% | 36.01% | 27.99% |
| Capital Expenditure | -27.16% | -76.71% | -194.04% | -415.04% | -2,308.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 60.36% | 51.41% | 102.53% | 33.82% | -1,220.09% |
| Cash from Investing | 60.03% | 51.02% | 101.79% | 33.10% | -1,222.34% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 400.25% | 78.90% | -67.50% | 4.83% | -44.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -100.01% | -101.74% |
| Cash from Financing | 438.97% | -24.75% | -86.20% | -66.16% | -83.54% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 100.91% | 133.00% | -833.71% | -577.06% | -307.01% |